Jonathan Milner

After a decade in the life sciences industry as an academic researcher, Jonathan moved to become an experienced entrepreneur and investor. Passionate about supporting UK life science and high-tech start-ups, he is Chairman of Camallergy and non-executive director of PhoreMost Ltd, Censo Biotechnologies Ltd and Healx Ltd. He founded Abcam in in 1998 with David Cleevely and Professor Tony Kouzarides and has since provided considerable investment and support to over 60 companies and has assisted three technology companies to IPO on the London AIM stock exchange.